Recombinant Human DRD2 Protein，His & Myc

Dopamine D2 receptors (DRD2) play a crucial role in the central nervous system, influencing various physiological functions and behaviors, including motivation, reward processing, and the regulation of mood. Dysregulation of DRD2 signaling has been implicated in several neuropsychiatric disorders, such as schizophrenia, bipolar disorder, and drug addiction. Given its significance, researchers are increasingly focusing on the development of recombinant DRD2 proteins to better understand receptor structure, function, and pharmacology. Recombinant protein expression systems, such as bacteria, yeast, or mammalian cells, allow for the production of large quantities of functional DRD2, facilitating biochemical assays, structural studies, and drug screening applications. Furthermore, these studies can elucidate the receptor's signaling mechanisms, identify potential therapeutic targets, and aid in the design of novel psychotropic medications. Recent advancements in techniques such as X-ray crystallography and cryo-electron microscopy have further propelled the investigation of DRD2, enabling the characterization of its conformational states and interactions with ligands. This research is vital for advancing our understanding of dopamine-related pathways and developing effective treatments for neuropsychiatric disorders.